Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old.
Liu Y, Liu H, Liu H, He P, Li J, Liu X, Chen L, Wang M, Xi J, Wang H, Zhang H, Zhu Y, Zhu W, Ning J, Guo C, Sun C, Zhang M.
Liu Y, et al. Among authors: liu h, liu x.
Oncol Lett. 2016 Dec;12(6):5205-5210. doi: 10.3892/ol.2016.5337. Epub 2016 Nov 2.
Oncol Lett. 2016.
PMID: 28105230
Free PMC article.